Chargement en cours...
Nivolumab-induced fulminant diabetic ketoacidosis followed by thyroiditis
Five days following the 3rd cycle of nivolumab, a monoclonal antibody, which acts as immune checkpoint inhibitor against the programmed cell death protein-1, for metastatic lung adenocarcinoma, a 56-year-old woman presented at the hospital critically ill. On admission, she had severe diabetic ketoac...
Enregistré dans:
| Publié dans: | Endocrinol Diabetes Metab Case Rep |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Bioscientifica Ltd
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5863245/ https://ncbi.nlm.nih.gov/pubmed/29576870 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EDM-18-0111 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|